Explore how sponsors can incorporate MRD across early-phase and registrational development, with a focus on regulatory positioning and clinical pharmacology implications.

This podcast offers practical insights for organizations looking to modernize commercialization strategies and improve patient access in a rapidly changing healthcare landscape.

Geographic atrophy treatments are approved in the US but not Europe due to differing regulatory perspectives on clinical benefit measurement.

As FDA moves toward one pivotal trial approvals, learn how real world evidence can de‑risk development, inform trial design and support regulatory and commercial success.

Explore the realities shaping trial delivery, from critical site needs to the evolving role of CRAs and study teams, and the challenges, priorities and innovations driving stronger...

In this podcast, experts explore how connected care, patient-centered collaboration and better communication can improve access, support and outcomes across healthcare.